 | • レポートコード：MRC2-11QY10673 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はチゲサイクリンのグローバル市場について調査・分析したレポートです。種類別（グラム陽性菌、グラム陰性菌）市場規模、用途別（皮膚・軟部組織感染症、複雑性腹腔内感染症、市中感染性細菌性肺炎）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別チゲサイクリンの競争状況、市場シェア ・世界のチゲサイクリン市場：種類別市場規模 2015年-2020年（グラム陽性菌、グラム陰性菌） ・世界のチゲサイクリン市場：種類別市場規模予測 2021年-2026年（グラム陽性菌、グラム陰性菌） ・世界のチゲサイクリン市場：用途別市場規模 2015年-2020年（皮膚・軟部組織感染症、複雑性腹腔内感染症、市中感染性細菌性肺炎） ・世界のチゲサイクリン市場：用途別市場規模予測 2021年-2026年（皮膚・軟部組織感染症、複雑性腹腔内感染症、市中感染性細菌性肺炎） ・北米のチゲサイクリン市場分析：米国、カナダ ・ヨーロッパのチゲサイクリン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのチゲサイクリン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のチゲサイクリン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのチゲサイクリン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Hisun Pharma、Hansoh Pharma、Jiagsu Aosaikang Pharmaceutical、HICIN Pharma、Abbott Laboratories、Amgen、Astrazeneca、Merck、Novartis、Roche Holdings、Johnson & Johnson、Sanofi、Lifecare Innovations、Progen Nutraceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Tigecycline Market
The global Tigecycline market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Tigecycline Scope and Market Size
Tigecycline market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tigecycline market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Tigecycline market is segmented into
Gram Positive Bacteria
Gram Negative Bacteria
Segment by Application, the Tigecycline market is segmented into
Skin & Soft Tissue Infections
Complicated Intra-abdominal Infections
Community-acquired Bacterial Pneumonia
Regional and Country-level Analysis
The Tigecycline market is analysed and market size information is provided by regions (countries).
The key regions covered in the Tigecycline market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Tigecycline Market Share Analysis
Tigecycline market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Tigecycline business, the date to enter into the Tigecycline market, Tigecycline product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Hisun Pharma
Hansoh Pharma
Jiagsu Aosaikang Pharmaceutical
HICIN Pharma
Abbott Laboratories
Amgen
Astrazeneca
Merck
Novartis
Roche Holdings
Johnson & Johnson
Sanofi
Lifecare Innovations
Progen Nutraceuticals
1 Study Coverage
1.1 Tigecycline Product Introduction
1.2 Market Segments
1.3 Key Tigecycline Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Tigecycline Market Size Growth Rate by Type
1.4.2 Gram Positive Bacteria
1.4.3 Gram Negative Bacteria
1.5 Market by Application
1.5.1 Global Tigecycline Market Size Growth Rate by Application
1.5.2 Skin & Soft Tissue Infections
1.5.3 Complicated Intra-abdominal Infections
1.5.4 Community-acquired Bacterial Pneumonia
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Tigecycline Market Size, Estimates and Forecasts
2.1.1 Global Tigecycline Revenue 2015-2026
2.1.2 Global Tigecycline Sales 2015-2026
2.2 Global Tigecycline, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Tigecycline Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Tigecycline Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Tigecycline Competitor Landscape by Players
3.1 Tigecycline Sales by Manufacturers
3.1.1 Tigecycline Sales by Manufacturers (2015-2020)
3.1.2 Tigecycline Sales Market Share by Manufacturers (2015-2020)
3.2 Tigecycline Revenue by Manufacturers
3.2.1 Tigecycline Revenue by Manufacturers (2015-2020)
3.2.2 Tigecycline Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Tigecycline Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Tigecycline Revenue in 2019
3.2.5 Global Tigecycline Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Tigecycline Price by Manufacturers
3.4 Tigecycline Manufacturing Base Distribution, Product Types
3.4.1 Tigecycline Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Tigecycline Product Type
3.4.3 Date of International Manufacturers Enter into Tigecycline Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Tigecycline Market Size by Type (2015-2020)
4.1.1 Global Tigecycline Sales by Type (2015-2020)
4.1.2 Global Tigecycline Revenue by Type (2015-2020)
4.1.3 Tigecycline Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Tigecycline Market Size Forecast by Type (2021-2026)
4.2.1 Global Tigecycline Sales Forecast by Type (2021-2026)
4.2.2 Global Tigecycline Revenue Forecast by Type (2021-2026)
4.2.3 Tigecycline Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Tigecycline Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Tigecycline Market Size by Application (2015-2020)
5.1.1 Global Tigecycline Sales by Application (2015-2020)
5.1.2 Global Tigecycline Revenue by Application (2015-2020)
5.1.3 Tigecycline Price by Application (2015-2020)
5.2 Tigecycline Market Size Forecast by Application (2021-2026)
5.2.1 Global Tigecycline Sales Forecast by Application (2021-2026)
5.2.2 Global Tigecycline Revenue Forecast by Application (2021-2026)
5.2.3 Global Tigecycline Price Forecast by Application (2021-2026)
6 North America
6.1 North America Tigecycline by Country
6.1.1 North America Tigecycline Sales by Country
6.1.2 North America Tigecycline Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Tigecycline Market Facts & Figures by Type
6.3 North America Tigecycline Market Facts & Figures by Application
7 Europe
7.1 Europe Tigecycline by Country
7.1.1 Europe Tigecycline Sales by Country
7.1.2 Europe Tigecycline Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Tigecycline Market Facts & Figures by Type
7.3 Europe Tigecycline Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Tigecycline by Region
8.1.1 Asia Pacific Tigecycline Sales by Region
8.1.2 Asia Pacific Tigecycline Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Tigecycline Market Facts & Figures by Type
8.3 Asia Pacific Tigecycline Market Facts & Figures by Application
9 Latin America
9.1 Latin America Tigecycline by Country
9.1.1 Latin America Tigecycline Sales by Country
9.1.2 Latin America Tigecycline Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Tigecycline Market Facts & Figures by Type
9.3 Central & South America Tigecycline Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Tigecycline by Country
10.1.1 Middle East and Africa Tigecycline Sales by Country
10.1.2 Middle East and Africa Tigecycline Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Tigecycline Market Facts & Figures by Type
10.3 Middle East and Africa Tigecycline Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Tigecycline Products Offered
11.1.5 Pfizer Related Developments
11.2 Hisun Pharma
11.2.1 Hisun Pharma Corporation Information
11.2.2 Hisun Pharma Description and Business Overview
11.2.3 Hisun Pharma Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Hisun Pharma Tigecycline Products Offered
11.2.5 Hisun Pharma Related Developments
11.3 Hansoh Pharma
11.3.1 Hansoh Pharma Corporation Information
11.3.2 Hansoh Pharma Description and Business Overview
11.3.3 Hansoh Pharma Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Hansoh Pharma Tigecycline Products Offered
11.3.5 Hansoh Pharma Related Developments
11.4 Jiagsu Aosaikang Pharmaceutical
11.4.1 Jiagsu Aosaikang Pharmaceutical Corporation Information
11.4.2 Jiagsu Aosaikang Pharmaceutical Description and Business Overview
11.4.3 Jiagsu Aosaikang Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Jiagsu Aosaikang Pharmaceutical Tigecycline Products Offered
11.4.5 Jiagsu Aosaikang Pharmaceutical Related Developments
11.5 HICIN Pharma
11.5.1 HICIN Pharma Corporation Information
11.5.2 HICIN Pharma Description and Business Overview
11.5.3 HICIN Pharma Sales, Revenue and Gross Margin (2015-2020)
11.5.4 HICIN Pharma Tigecycline Products Offered
11.5.5 HICIN Pharma Related Developments
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Corporation Information
11.6.2 Abbott Laboratories Description and Business Overview
11.6.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Abbott Laboratories Tigecycline Products Offered
11.6.5 Abbott Laboratories Related Developments
11.7 Amgen
11.7.1 Amgen Corporation Information
11.7.2 Amgen Description and Business Overview
11.7.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Amgen Tigecycline Products Offered
11.7.5 Amgen Related Developments
11.8 Astrazeneca
11.8.1 Astrazeneca Corporation Information
11.8.2 Astrazeneca Description and Business Overview
11.8.3 Astrazeneca Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Astrazeneca Tigecycline Products Offered
11.8.5 Astrazeneca Related Developments
11.9 Merck
11.9.1 Merck Corporation Information
11.9.2 Merck Description and Business Overview
11.9.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Merck Tigecycline Products Offered
11.9.5 Merck Related Developments
11.10 Novartis
11.10.1 Novartis Corporation Information
11.10.2 Novartis Description and Business Overview
11.10.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Novartis Tigecycline Products Offered
11.10.5 Novartis Related Developments
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Tigecycline Products Offered
11.1.5 Pfizer Related Developments
11.12 Johnson & Johnson
11.12.1 Johnson & Johnson Corporation Information
11.12.2 Johnson & Johnson Description and Business Overview
11.12.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Johnson & Johnson Products Offered
11.12.5 Johnson & Johnson Related Developments
11.13 Sanofi
11.13.1 Sanofi Corporation Information
11.13.2 Sanofi Description and Business Overview
11.13.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Sanofi Products Offered
11.13.5 Sanofi Related Developments
11.14 Lifecare Innovations
11.14.1 Lifecare Innovations Corporation Information
11.14.2 Lifecare Innovations Description and Business Overview
11.14.3 Lifecare Innovations Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Lifecare Innovations Products Offered
11.14.5 Lifecare Innovations Related Developments
11.15 Progen Nutraceuticals
11.15.1 Progen Nutraceuticals Corporation Information
11.15.2 Progen Nutraceuticals Description and Business Overview
11.15.3 Progen Nutraceuticals Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Progen Nutraceuticals Products Offered
11.15.5 Progen Nutraceuticals Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Tigecycline Market Estimates and Projections by Region
12.1.1 Global Tigecycline Sales Forecast by Regions 2021-2026
12.1.2 Global Tigecycline Revenue Forecast by Regions 2021-2026
12.2 North America Tigecycline Market Size Forecast (2021-2026)
12.2.1 North America: Tigecycline Sales Forecast (2021-2026)
12.2.2 North America: Tigecycline Revenue Forecast (2021-2026)
12.2.3 North America: Tigecycline Market Size Forecast by Country (2021-2026)
12.3 Europe Tigecycline Market Size Forecast (2021-2026)
12.3.1 Europe: Tigecycline Sales Forecast (2021-2026)
12.3.2 Europe: Tigecycline Revenue Forecast (2021-2026)
12.3.3 Europe: Tigecycline Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Tigecycline Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Tigecycline Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Tigecycline Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Tigecycline Market Size Forecast by Region (2021-2026)
12.5 Latin America Tigecycline Market Size Forecast (2021-2026)
12.5.1 Latin America: Tigecycline Sales Forecast (2021-2026)
12.5.2 Latin America: Tigecycline Revenue Forecast (2021-2026)
12.5.3 Latin America: Tigecycline Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Tigecycline Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Tigecycline Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Tigecycline Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Tigecycline Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Tigecycline Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Tigecycline Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Tigecycline Market Segments
Table 2. Ranking of Global Top Tigecycline Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Tigecycline Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Gram Positive Bacteria
Table 5. Major Manufacturers of Gram Negative Bacteria
Table 6. Global Tigecycline Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Tigecycline Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Tigecycline Sales by Regions 2015-2020 (K MT)
Table 9. Global Tigecycline Sales Market Share by Regions (2015-2020)
Table 10. Global Tigecycline Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Tigecycline Sales by Manufacturers (2015-2020) (K MT)
Table 12. Global Tigecycline Sales Share by Manufacturers (2015-2020)
Table 13. Global Tigecycline Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Tigecycline by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tigecycline as of 2019)
Table 15. Tigecycline Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Tigecycline Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Tigecycline Price (2015-2020) (USD/MT)
Table 18. Tigecycline Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Tigecycline Product Type
Table 20. Date of International Manufacturers Enter into Tigecycline Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Tigecycline Sales by Type (2015-2020) (K MT)
Table 23. Global Tigecycline Sales Share by Type (2015-2020)
Table 24. Global Tigecycline Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Tigecycline Revenue Share by Type (2015-2020)
Table 26. Tigecycline Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global Tigecycline Sales by Application (2015-2020) (K MT)
Table 28. Global Tigecycline Sales Share by Application (2015-2020)
Table 29. North America Tigecycline Sales by Country (2015-2020) (K MT)
Table 30. North America Tigecycline Sales Market Share by Country (2015-2020)
Table 31. North America Tigecycline Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Tigecycline Revenue Market Share by Country (2015-2020)
Table 33. North America Tigecycline Sales by Type (2015-2020) (K MT)
Table 34. North America Tigecycline Sales Market Share by Type (2015-2020)
Table 35. North America Tigecycline Sales by Application (2015-2020) (K MT)
Table 36. North America Tigecycline Sales Market Share by Application (2015-2020)
Table 37. Europe Tigecycline Sales by Country (2015-2020) (K MT)
Table 38. Europe Tigecycline Sales Market Share by Country (2015-2020)
Table 39. Europe Tigecycline Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Tigecycline Revenue Market Share by Country (2015-2020)
Table 41. Europe Tigecycline Sales by Type (2015-2020) (K MT)
Table 42. Europe Tigecycline Sales Market Share by Type (2015-2020)
Table 43. Europe Tigecycline Sales by Application (2015-2020) (K MT)
Table 44. Europe Tigecycline Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Tigecycline Sales by Region (2015-2020) (K MT)
Table 46. Asia Pacific Tigecycline Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Tigecycline Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Tigecycline Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Tigecycline Sales by Type (2015-2020) (K MT)
Table 50. Asia Pacific Tigecycline Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Tigecycline Sales by Application (2015-2020) (K MT)
Table 52. Asia Pacific Tigecycline Sales Market Share by Application (2015-2020)
Table 53. Latin America Tigecycline Sales by Country (2015-2020) (K MT)
Table 54. Latin America Tigecycline Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Tigecycline Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Tigecycline Revenue Market Share by Country (2015-2020)
Table 57. Latin America Tigecycline Sales by Type (2015-2020) (K MT)
Table 58. Latin America Tigecycline Sales Market Share by Type (2015-2020)
Table 59. Latin America Tigecycline Sales by Application (2015-2020) (K MT)
Table 60. Latin America Tigecycline Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Tigecycline Sales by Country (2015-2020) (K MT)
Table 62. Middle East and Africa Tigecycline Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Tigecycline Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Tigecycline Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Tigecycline Sales by Type (2015-2020) (K MT)
Table 66. Middle East and Africa Tigecycline Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Tigecycline Sales by Application (2015-2020) (K MT)
Table 68. Middle East and Africa Tigecycline Sales Market Share by Application (2015-2020)
Table 69. Pfizer Corporation Information
Table 70. Pfizer Description and Major Businesses
Table 71. Pfizer Tigecycline Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. Pfizer Product
Table 73. Pfizer Recent Development
Table 74. Hisun Pharma Corporation Information
Table 75. Hisun Pharma Description and Major Businesses
Table 76. Hisun Pharma Tigecycline Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Hisun Pharma Product
Table 78. Hisun Pharma Recent Development
Table 79. Hansoh Pharma Corporation Information
Table 80. Hansoh Pharma Description and Major Businesses
Table 81. Hansoh Pharma Tigecycline Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Hansoh Pharma Product
Table 83. Hansoh Pharma Recent Development
Table 84. Jiagsu Aosaikang Pharmaceutical Corporation Information
Table 85. Jiagsu Aosaikang Pharmaceutical Description and Major Businesses
Table 86. Jiagsu Aosaikang Pharmaceutical Tigecycline Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Jiagsu Aosaikang Pharmaceutical Product
Table 88. Jiagsu Aosaikang Pharmaceutical Recent Development
Table 89. HICIN Pharma Corporation Information
Table 90. HICIN Pharma Description and Major Businesses
Table 91. HICIN Pharma Tigecycline Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. HICIN Pharma Product
Table 93. HICIN Pharma Recent Development
Table 94. Abbott Laboratories Corporation Information
Table 95. Abbott Laboratories Description and Major Businesses
Table 96. Abbott Laboratories Tigecycline Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Abbott Laboratories Product
Table 98. Abbott Laboratories Recent Development
Table 99. Amgen Corporation Information
Table 100. Amgen Description and Major Businesses
Table 101. Amgen Tigecycline Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Amgen Product
Table 103. Amgen Recent Development
Table 104. Astrazeneca Corporation Information
Table 105. Astrazeneca Description and Major Businesses
Table 106. Astrazeneca Tigecycline Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Astrazeneca Product
Table 108. Astrazeneca Recent Development
Table 109. Merck Corporation Information
Table 110. Merck Description and Major Businesses
Table 111. Merck Tigecycline Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Merck Product
Table 113. Merck Recent Development
Table 114. Novartis Corporation Information
Table 115. Novartis Description and Major Businesses
Table 116. Novartis Tigecycline Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Novartis Product
Table 118. Novartis Recent Development
Table 119. Roche Holdings Corporation Information
Table 120. Roche Holdings Description and Major Businesses
Table 121. Roche Holdings Tigecycline Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Roche Holdings Product
Table 123. Roche Holdings Recent Development
Table 124. Johnson & Johnson Corporation Information
Table 125. Johnson & Johnson Description and Major Businesses
Table 126. Johnson & Johnson Tigecycline Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 127. Johnson & Johnson Product
Table 128. Johnson & Johnson Recent Development
Table 129. Sanofi Corporation Information
Table 130. Sanofi Description and Major Businesses
Table 131. Sanofi Tigecycline Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 132. Sanofi Product
Table 133. Sanofi Recent Development
Table 134. Lifecare Innovations Corporation Information
Table 135. Lifecare Innovations Description and Major Businesses
Table 136. Lifecare Innovations Tigecycline Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 137. Lifecare Innovations Product
Table 138. Lifecare Innovations Recent Development
Table 139. Progen Nutraceuticals Corporation Information
Table 140. Progen Nutraceuticals Description and Major Businesses
Table 141. Progen Nutraceuticals Tigecycline Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 142. Progen Nutraceuticals Product
Table 143. Progen Nutraceuticals Recent Development
Table 144. Global Tigecycline Sales Forecast by Regions (2021-2026) (K MT)
Table 145. Global Tigecycline Sales Market Share Forecast by Regions (2021-2026)
Table 146. Global Tigecycline Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 147. Global Tigecycline Revenue Market Share Forecast by Regions (2021-2026)
Table 148. North America: Tigecycline Sales Forecast by Country (2021-2026) (K MT)
Table 149. North America: Tigecycline Revenue Forecast by Country (2021-2026) (US$ Million)
Table 150. Europe: Tigecycline Sales Forecast by Country (2021-2026) (K MT)
Table 151. Europe: Tigecycline Revenue Forecast by Country (2021-2026) (US$ Million)
Table 152. Asia Pacific: Tigecycline Sales Forecast by Region (2021-2026) (K MT)
Table 153. Asia Pacific: Tigecycline Revenue Forecast by Region (2021-2026) (US$ Million)
Table 154. Latin America: Tigecycline Sales Forecast by Country (2021-2026) (K MT)
Table 155. Latin America: Tigecycline Revenue Forecast by Country (2021-2026) (US$ Million)
Table 156. Middle East and Africa: Tigecycline Sales Forecast by Country (2021-2026) (K MT)
Table 157. Middle East and Africa: Tigecycline Revenue Forecast by Country (2021-2026) (US$ Million)
Table 158. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 159. Key Challenges
Table 160. Market Risks
Table 161. Main Points Interviewed from Key Tigecycline Players
Table 162. Tigecycline Customers List
Table 163. Tigecycline Distributors List
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Tigecycline Product Picture
Figure 2. Global Tigecycline Sales Market Share by Type in 2020 & 2026
Figure 3. Gram Positive Bacteria Product Picture
Figure 4. Gram Negative Bacteria Product Picture
Figure 5. Global Tigecycline Sales Market Share by Application in 2020 & 2026
Figure 6. Skin & Soft Tissue Infections
Figure 7. Complicated Intra-abdominal Infections
Figure 8. Community-acquired Bacterial Pneumonia
Figure 9. Tigecycline Report Years Considered
Figure 10. Global Tigecycline Market Size 2015-2026 (US$ Million)
Figure 11. Global Tigecycline Sales 2015-2026 (K MT)
Figure 12. Global Tigecycline Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Tigecycline Sales Market Share by Region (2015-2020)
Figure 14. Global Tigecycline Sales Market Share by Region in 2019
Figure 15. Global Tigecycline Revenue Market Share by Region (2015-2020)
Figure 16. Global Tigecycline Revenue Market Share by Region in 2019
Figure 17. Global Tigecycline Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Tigecycline Revenue in 2019
Figure 19. Tigecycline Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Tigecycline Sales Market Share by Type (2015-2020)
Figure 21. Global Tigecycline Sales Market Share by Type in 2019
Figure 22. Global Tigecycline Revenue Market Share by Type (2015-2020)
Figure 23. Global Tigecycline Revenue Market Share by Type in 2019
Figure 24. Global Tigecycline Market Share by Price Range (2015-2020)
Figure 25. Global Tigecycline Sales Market Share by Application (2015-2020)
Figure 26. Global Tigecycline Sales Market Share by Application in 2019
Figure 27. Global Tigecycline Revenue Market Share by Application (2015-2020)
Figure 28. Global Tigecycline Revenue Market Share by Application in 2019
Figure 29. North America Tigecycline Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America Tigecycline Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Tigecycline Sales Market Share by Country in 2019
Figure 32. North America Tigecycline Revenue Market Share by Country in 2019
Figure 33. U.S. Tigecycline Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. Tigecycline Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Tigecycline Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada Tigecycline Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Tigecycline Market Share by Type in 2019
Figure 38. North America Tigecycline Market Share by Application in 2019
Figure 39. Europe Tigecycline Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe Tigecycline Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Tigecycline Sales Market Share by Country in 2019
Figure 42. Europe Tigecycline Revenue Market Share by Country in 2019
Figure 43. Germany Tigecycline Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany Tigecycline Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Tigecycline Sales Growth Rate (2015-2020) (K MT)
Figure 46. France Tigecycline Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Tigecycline Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. Tigecycline Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Tigecycline Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy Tigecycline Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Tigecycline Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia Tigecycline Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Tigecycline Market Share by Type in 2019
Figure 54. Europe Tigecycline Market Share by Application in 2019
Figure 55. Asia Pacific Tigecycline Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific Tigecycline Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Tigecycline Sales Market Share by Region in 2019
Figure 58. Asia Pacific Tigecycline Revenue Market Share by Region in 2019
Figure 59. China Tigecycline Sales Growth Rate (2015-2020) (K MT)
Figure 60. China Tigecycline Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Tigecycline Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan Tigecycline Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Tigecycline Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea Tigecycline Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Tigecycline Sales Growth Rate (2015-2020) (K MT)
Figure 66. India Tigecycline Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Tigecycline Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia Tigecycline Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Tigecycline Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan Tigecycline Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Tigecycline Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia Tigecycline Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Tigecycline Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand Tigecycline Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Tigecycline Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia Tigecycline Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Tigecycline Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines Tigecycline Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Tigecycline Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam Tigecycline Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Tigecycline Market Share by Type in 2019
Figure 82. Asia Pacific Tigecycline Market Share by Application in 2019
Figure 83. Latin America Tigecycline Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America Tigecycline Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Tigecycline Sales Market Share by Country in 2019
Figure 86. Latin America Tigecycline Revenue Market Share by Country in 2019
Figure 87. Mexico Tigecycline Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico Tigecycline Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Tigecycline Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil Tigecycline Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Tigecycline Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina Tigecycline Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Tigecycline Market Share by Type in 2019
Figure 94. Latin America Tigecycline Market Share by Application in 2019
Figure 95. Middle East and Africa Tigecycline Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa Tigecycline Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Tigecycline Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Tigecycline Revenue Market Share by Country in 2019
Figure 99. Turkey Tigecycline Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey Tigecycline Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Tigecycline Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia Tigecycline Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Tigecycline Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E Tigecycline Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Tigecycline Market Share by Type in 2019
Figure 106. Middle East and Africa Tigecycline Market Share by Application in 2019
Figure 107. North America Tigecycline Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 108. North America Tigecycline Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Tigecycline Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. Europe Tigecycline Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Tigecycline Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Asia Pacific Tigecycline Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Tigecycline Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Latin America Tigecycline Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Tigecycline Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Middle East and Africa Tigecycline Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
病院治療グラム陰性菌感染症の世界市場（～2026年） Gram-negative bacteria are non-pathogenic in person with the normal immune system. However, in person with a weak immune system having gram negative bacteria can behave as significant pathogens. The ability to prevent the effect of such micro-organisms is significantly hampered by the resistance of …- 市中肺炎（CAP）の世界市場（～2026年） Community-acquired pneumonia (CAP) refers to pneumonia (any of several lung diseases) contracted by a person with little contact with the healthcare system. The market of CAP treatment and diagnosis in further segmented with respect to major geographies of North America, Europe, Asia-Pacific, and La…
- 医療関連感染（HAI）診断の世界市場（～2026年） Patients may catch infections during they are in the hospital, the hospital acquired infection test is used to diagnose those infections. The industry is anticipated to witness a significant growth in the next few years. One of the key factors driving industry growth is the rising geriatric populati…
- 壊死性皮膚感染症治療の世界市場（～2026年） Necrotizing skin infections ranks among the most rarely found diseases but are highly lethal infection. Necrotizing skin infection arise primarily in any layer of skin soft tissue such as dermis and epidermis that are associated with necrotizing changes. Necrotizing skin infection is also commonly c…
- 医療関連感染（HAI）管理の世界市場（～2026年） A hospital-acquired infection (HAI), also known as a nosocomial infection, is an infection that is acquired in a hospital or other health care facility. The rise in the incidences of different types of hospital acquired infections, innovative technologies implemented in devices that control infectio…